Preview

Problems of Endocrinology

Advanced search

Short stature due to intrauterine growth retardation. Clinical and hormonal-metabolic features, possibilities of growth-stimulating therapy

https://doi.org/10.14341/probl13178

Abstract

The article presents data about short stature due to intrauterine development delay. This type of short stature — separate nosology, unites children born small for gestation age. The majority of them in the first years of life have accelerated growth rates, allowing the child to normalize their weight-growth indicators and catch up in the development of peers. In the absence of an accelerated growth rates, children have a high risk of lagging behind in physical development throughout childhood, achieving low final growth and becoming short adults. In addition, the fact of birth with small body sizes is associated with a number of hormonal and metabolic features, a risk of metabolic syndrome in adult years.

It is assumed that the absence of postnatal growth acceleration is due to various damages to the GH-IGF1 axis (partial GH deficiency, partial resistance to GH, partial resistance to IGF1). Growth hormone therapy, initiated early in life, is able to normalize growth rates in childhood and ultimately significantly improve or normalize the final growth of short stature children born small for gestational age.

About the Author

E. V. Nagaeva
Endocrinology Research Centre
Russian Federation

Elena V. Nagaeva - MD, PhD.

Moscow.

SPIN-код: 4878-7810


Competing Interests:

None



References

1. Lee PA, Chernausek SD, Hokken-Koelega ACS, Czernichow P. International small for gestational age advisory board consensus development conference statement: management of short children born small for gestational age, April 24–October 1, 2001. Pediatrics. 2003;111(6):1253-1261. doi: https://doi.org/10.1542/peds.111.6.1253

2. Clayton PE, Cianfarani S, Czernichow P, et al. Management of the child born small for gestational age through to adulthood: A consensus statement of the international societies of pediatric endocrinology and the growth hormone research society. J Clin Endocrinol Metab. 2007;92(3):804-810. doi: https://doi.org/10.1210/jc.2006-2017

3. Karlberg J, Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res. 1995;38(5):733-739. doi: https://doi.org/10.1203/00006450-199511000-00017

4. Lee ACC, Katz J, Blencowe H, et al. National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010. Lancet Glob Heal. 2013;1(1):e26-e36. doi: https://doi.org/10.1016/S2214-109X(13)70006-8

5. Tudehope D, Vento M, Bhutta Z, Pachi P. Nutritional requirements and feeding recommendations for small for gestational age infants. J Pediatr. 2013;162(3):S81-S89. doi: https://doi.org/10.1016/j.jpeds.2012.11.057

6. Campisi SC, Carbone SE, Zlotkin S. Catch-up growth in full-term small for gestational age infants: A systematic review. Adv Nutr. 2019;10(1):104-111. doi: https://doi.org/10.1093/advances/nmy091

7. Chrestani MA, Santos IS, Horta BL, et al. Associated factors for accelerated growth in childhood: A systematic review. Matern Child Health J. 2013;17(3):512-519. doi: https://doi.org/10.1007/s10995-012-1025-8

8. Katz J, Wu LA, Mullany LC, et al. Prevalence of small-for-gestational-age and its mortality risk varies by choice of birth-weight-for-gestation reference population. PLoS One. 2014;9(3):e92074. doi: https://doi.org/10.1371/journal.pone.0092074

9. de Onis M. Update on the implementation of the WHO child growth standards. PLoS ONE. Vol 9. ; 2013:75-82. doi: https://doi.org/10.1159/000342550

10. Villar J, Cheikh IL, Victora CG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the newborn cross-sectional study of the INTERGROWTH-21st project. Lancet. 2014;384(9946):857-868 doi: https://doi.org/10.1016/S0140-6736(14)60932-6

11. Logvinova II, Emelyanova AS. Risk factors for the birth of low-weight children, the structure of morbidity, mortality. Russian Pediatric Journal. 2000;4:50-52. (In Russ.).

12. Ross MG, Editor C, Smith C, et al. Fetal growth restriction. Obstetrics and gynecology [Internet]. [cited Sep 15, 2020]. Available from: https://emedicine.medscape.com/article/261226-overview

13. Nardozza LMM, Caetano ACR, Zamarian ACP, et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet. 2017;295(5):1061-1077. doi: https://doi.org/10.1007/s00404-017-4341-9

14. Stephenson T., Symonds M.E. Maternal nutrition as a determinant of birth weight. Archives of disease in childhood. Fetal and neonatal edition [Internet]. 2002;86(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1721347/pdf/v086p000F4.pdf

15. Finken MJJ, van der Steen M, Smeets CCJ, et al. Children Born Small for Gestational Age: Differential Diagnosis, Molecular Genetic Evaluation, and Implications. Endocr Rev. 2018;39(6):851-894. doi: https://doi.org/10.1210/er.2018-00083

16. Macdonald-Wallis C, Silverwood RJ, de Stavola BL, et al. Antenatal blood pressure for prediction of pre-eclampsia, preterm birth, and small for gestational age babies: development and validation in two general population cohorts. BMJ. 2015;351(17-5):h5948-h5948. doi: https://doi.org/10.1136/bmj.h5948

17. Allen VM, Joseph K, Murphy KE, et al. The effect of hypertensive disorders in pregnancy on small for gestational age and stillbirth: a population based study. BMC Pregnancy Childbirth. 2004;4(1):17. doi: https://doi.org/10.1186/1471-2393-4-17

18. Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Maternal Cardiovascular Impairment in Pregnancies Complicated by Severe Fetal Growth Restriction. Hypertension. 2012;60(2):437-443. doi: https://doi.org/10.1161/HYPERTENSIONAHA.112.194159

19. Ahluwalia IB, Merritt R, Beck LF, Rogers M. Multiple lifestyle and psychosocial risk and delivery of small for gestational age infants. Obstetrics and gynecology. 2001;97(5):649-656 doi: https://doi.org/10.1016/s0029-7844(01)01324-2

20. Anderson NH, Sadler LC, Stewart AW, et al. Independent risk factors for infants who are small for gestational age by customised birthweight centiles in a multi-ethnic New Zealand population. Aust New Zeal J Obstet Gynaecol. 2013;53(2):136-142. doi: https://doi.org/10.1111/ajo.12016

21. Zhang X, Cnattingius S, Platt RW, et al. Are babies born to short, primiparous, or thin mothers “Normally” or “Abnormally” small? J Pediatr. 2007;150(6):603-607.e3. doi: https://doi.org/10.1016/j.jpeds.2007.01.048

22. Woods K, Camacho-Hübner C, Barter D, et al. Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature. Acta Paediatr. 1997;86(S423):39-45. doi: https://doi.org/10.1111/j.1651-2227.1997.tb18367.x

23. Burton GJ, Jauniaux E. Pathophysiology of placental-derived fetal growth restriction. Am J Obstet Gynecol. 2018;218(2):S745-S761. doi: https://doi.org/10.1016/j.ajog.2017.11.577

24. Townsend R, Khalil A. Fetal growth restriction in twins. Best Pract Res Clin Obstet Gynaecol. 2018;49(2):79-88. doi: https://doi.org/10.1016/j.bpobgyn.2018.02.004

25. Woods K, Camacho-Hübner C, Barter D, et al. Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature. Acta Paediatr. 1997;86(S423):39-45. doi: https://doi.org/10.1111/j.1651-2227.1997.tb18367.x

26. David RJ, Collins JW. Differing Birth Weight among Infants of U.S.-Born Blacks, African-Born Blacks, and U.S.-Born Whites. N Engl J Med. 1997;337(17):1209-1214. doi: https://doi.org/10.1056/NEJM199710233371706

27. Strizhakov AN, Timokhina EV, Tarabrina TV. Clinical significance of insulin-like factor in fetal development delay syndrome. Questions of gynecology, obstetrics and perinatology. 2009;8(5):5-9 (in Russ.).

28. Gluckman PD. The endocrine regulation of fetal growth in late gestation: the role of insulin-like growth factors. J Clin Endocrinol Metab. 1995;80(4):1047-1050. doi: https://doi.org/10.1210/jcem.80.4.7714063

29. Gluckman PD, Harding JE. The Physiology and Pathophysiology of Intrauterine Growth Retardation. Horm Res. 1997;48(1):11-16. doi: https://doi.org/10.1159/000191257

30. Yang SW, Yu JS. Relationship of insulin-like growth factor-I, insulin-like growth factor binding protein-3, insulin, growth hormone in cord blood and maternal factors with birth height and birthweight. Pediatr Int. 2000;42(1):31-36. doi: https://doi.org/10.1046/j.1442-200x.2000.01167.x

31. Jaquet D, Leger J, Levy-Marchal C, et al. Ontogeny of Leptin in Human Fetuses and Newborns: Effect of Intrauterine Growth Retardation on Serum Leptin Concentrations. J Clin Endocrinol Metab. 1998;83(4):1243-1246. doi: https://doi.org/10.1210/jcem.83.4.4731

32. Albertsson-Wikland K, Boguszewski M, Karlberg J. Children Born Small-for-Gestational Age: Postnatal Growth and Hormonal Status. Horm Res Paediatr. 1998;49(S2):7-13. doi: https://doi.org/10.1159/000053080

33. Saenger P, Czernichow P, Hughes I, Reiter EO. Small for Gestational Age: Short Stature and Beyond. Endocr Rev. 2007;28(2):219-251. doi: https://doi.org/10.1210/er.2006-0039

34. Ong K, Dunger D. Birth weight, infant growth and insulin resistance. Eur J Endocrinol. 2004;151(S3):U131-U139. doi: https://doi.org/10.1530/eje.0.151u131

35. Campisi SC, Carbone SE, Zlotkin S. Catch-up growth in full-term small for gestational age infants: a systematic review. Adv Nut. 2019;10(1):104-111 doi: https://doi.org/10.1093/advances/nmy091

36. Бурлуцкая А.В., Шадрин С.А., Статова А.В. Физическое развитие детей, рожденных с задержкой внутриутробного развития // Эффективная фармакотерапия. — 2019. — T. 43. — №15. — С. 20-24. [Burlutskaya AV, Shadrin SA, Statova AV. Physical development of children born with developmental delay in utero. Effective pharmacotherapy. 2019;43(15):20-24 (In Russ.)]. doi: https://doi.org/10.33978/2307-3586-2019-15-43-20-24

37. Leger J., Limoni C., Collin D., et al. Prediction factors in the determination of final height in sibjects born small for gestational age. Pediatric research. 1998;43(6):808-812 doi: 10.1203/00006450-199806000-00015

38. Nagaeva EV. Growth, hormonal and metabolic status in children born with intrauterine developmental delay at different age periods. [dissertation]. Мoscow; 2021. 44 p. (In Russ.).

39. Waal WJ, Hokken-Koelega ACS, Stijnen T, et al. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. Clin Endocrinol (Oxf). 1994;41(5):621-630. doi: https://doi.org/10.1111/j.1365-2265.1994.tb01828.x

40. Woods KA, Van Helvoirt M, Ong KKL, et al. The Somatotropic Axis in Short Children Born Small for Gestational Age: Relation to Insulin Resistance. Pediatr Res. 2002;51(1):76-80. doi: https://doi.org/10.1203/00006450-200201000-00014

41. Leger J, Noel M, Limal JM, Czernichow P. Growth Factors and Intrauterine Growth Retardation. II. Serum Growth Hormone, Insulin-Like Growth Factor (IGF) I, and IGF-Binding Protein 3 Levels in Children with Intrauterine Growth Retar Age1. Pediatr Res. 1996;40(1):101-107. doi: https://doi.org/10.1203/00006450-199607000-00018

42. Arends NJT, Boonstra VH, Duivenvoorden HJ, et al. Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA). Clin Endocrinol (Oxf). 2005;62(1):44-50. doi: https://doi.org/10.1111/j.1365-2265.2004.02171.x

43. Ghirri P, Bernardini M, Vuerich M, et al. Adrenarche ,pubertal development ,age at menarche and final height of full-term ,born small for gestational age (SGA) girls. Gynecol Endocrinol. 2001;15(2):91-97. doi: https://doi.org/10.1080/gye.15.2.91.97

44. Tanaka T, Yokoya S, Seino Y, et al. Onset of puberty and near adult height in short children born small for gestational age and treated with GH: Interim analysis of up to 10 years of treatment in Japan. Clin Pediatr Endocrinol. 2015;24(1):15-25. doi: https://doi.org/10.1297/cpe.24.15

45. Verkauskiene R, Petraitiene I, Albertsson Wikland K. Puberty in Children Born Small for Gestational Age. Horm Res Paediatr. 2013;80(2):69-77. doi: https://doi.org/10.1159/000353759

46. Deng X, Li W, Luo Y, et al. Association between Small Fetuses and Puberty Timing: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2017;14(11):1377. doi: https://doi.org/10.3390/ijerph14111377

47. Neville KA. Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity. Arch Dis Child. 2005;90(3):258-261. doi: https://doi.org/10.1136/adc.2004.053959

48. Milovanovic I, Njuieyon F, Deghmoun S, et al. SGA Children with Moderate Catch-Up Growth Are Showing the Impaired Insulin Secretion at the Age of 4. PLoS One. 2014;9(6):e100337. doi: https://doi.org/10.1371/journal.pone.0100337

49. Lithell HO, McKeigue PM, Berglund L, et al. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ. 1996;312(7028):406-410. doi: https://doi.org/10.1136/bmj.312.7028.406

50. Crispi F, Crovetto F, Gratacos E. Intrauterine growth restriction and later cardiovascular function. Early Hum Dev. 2018;126(7028):23-27. doi: https://doi.org/10.1016/j.earlhumdev.2018.08.013

51. Harder T, Rodekamp E, Schellong K, et al. Birth weight and subsequent risk of type 2 diabetes: A meta-analysis. Am J Epidemiol. 2007;165(8):849-857. doi: https://doi.org/10.1093/aje/kwk071

52. Meas T, Deghmoun S, Alberti C, et al. Independent effects of weight gain and fetal programming on metabolic complications in adults born small for gestational age. Diabetologia. 2010;53(5):907-913 doi: https://doi.org/10.1007/s00125-009-1650-y

53. van Wassenaer A. Neurodevelopmental consequences of being born SGA. Pediatr Endocrinol Rev. 2005;2(3):372-377.

54. Baud O, Berkane N. Hormonal changes associated with intra-uterine growth restriction: impact on the developing brain and future neurodevelopment. Front Endocrinol (Lausanne). 2019;10. doi: https://doi.org/10.3389/fendo.2019.00179

55. Singh SP, Ehmann S, Snyder AK. Ethanol-induced changes in insulin-like growth factors and IGF gene expression in the fetal brain. Proc Soc Exp Biol Med. 1996;212(4):349-354 doi: https://doi.org/10.3181/00379727-212-44025

56. Strauss RS. Adult functional outcome of those born small for gestational age. JAMA. 2000;283(5):625. doi: https://doi.org/10.1001/jama.283.5.625

57. Cianfarani S, Maiorana A, Geremia C, et al. Blood glucose concentrations are reduced in children born Small for Gestational Age (SGA), and thyroid-stimulating hormone levels are increased in sga with blunted postnatal catch-up growth. J Clin Endocrinol Metab. 2003;88(6):2699-2705. doi: https://doi.org/10.1210/jc.2002-021882

58. Cohen P, Bright GM, Rogol AD, et al. Effects of dose and gender on the growth and growth factor response to gh in gh-deficient children: implications for efficacy and safety. J Clin Endocrinol Metab. 2002;87(1):90-98. doi: https://doi.org/10.1210/jcem.87.1.8150

59. Sas T, de Waal W, Mulder P, et al. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial 1. J Clin Endocrinol Metab. 1999;84(9):3064-3070. doi: https://doi.org/10.1210/jcem.84.9.5942

60. Leger J, Levy-Marchal C, Bloch J, et al. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. BMJ. 1997;315(7104):341-347. doi: https://doi.org/10.1136/bmj.315.7104.341

61. Carel J-C, Chatelain P, Rochiccioli P, Chaussain J-L. Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: results of a randomized controlled study. J Clin Endocrinol Metab. 2003;88(4):1587-1593. doi: https://doi.org/10.1210/jc.2002-021123

62. Horikawa R, Tanaka T, Nishinaga H, et al. The long-term safety and effectiveness of growth hormone treatment in Japanese children with short stature born small for gestational age. Clin Pediatr Endocrinol. 2020;29(4):159-171. doi: https://doi.org/10.1297/cpe.29.159

63. Houk CP, Lee PA. Early diagnosis and treatment referral of children born small for gestational age without catch-up growth are critical for optimal growth outcomes. Int J Pediatr Endocrinol. 2012;2012(1):11. doi: https://doi.org/10.1186/1687-9856-2012-11

64. Sas TCJ, Gerver W-JM, De Bruin R, et al. Body proportions during 6 years of GH treatment in children with short stature born small for gestational age participating in a randomised, double-blind, dose-response trial*. Clin Endocrinol (Oxf). 2000;53(6):675-681. doi: https://doi.org/10.1046/j.1365-2265.2000.01155.x

65. de Zegher F, Albertsson-Wikland K, Wollmann HA, et al. Growth Hormone Treatment of Short Children Born Small for Gestational Age: Growth Responses with Continuous and Discontinuous Regimens Over 6 Years 1. J Clin Endocrinol Metab. 2000;85(8):2816-2821. doi: https://doi.org/10.1210/jcem.85.8.6719

66. de Zegher F, Francois I, van Helvoirt M, et al. Growth Hormone Treatment of Short Children Born Small for Gestational Age. Trends Endocrinol Metab. 1998;9(6):233-237. doi: https://doi.org/10.1016/S1043-2760(98)00057-5

67. Ranke MB, Lindberg A. Predicting growth in response to growth hormone treatment. Growth Horm IGF Res. 2009;19(1):1-11. doi: https://doi.org/10.1016/j.ghir.2008.08.001

68. Van Pareren Y, Mulder P, Houdijk M, et al. Adult Height after Long-Term, Continuous Growth Hormone (GH) Treatment in Short Children Born Small for Gestational Age: Results of a Randomized, Double-Blind, Dose-Response GH Trial. J Clin Endocrinol Metab. 2003;88(8):3584-3590. doi: https://doi.org/10.1210/jc.2002-021172

69. Coutant R, Carel J-C, Letrait M, et al. Short Stature Associated with Intrauterine Growth Retardation: Final Height of Untreated and Growth Hormone-Treated Children. J Clin Endocrinol Metab. 1998;83(4):1070-1074. doi: https://doi.org/10.1210/jcem.83.4.4750

70. Zucchini S, Cacciari E, Balsamo A, et al. Adult height of short subjects of low birth weight with and without growth hormone treatment. Arch Dis Child.. 2001;84(4):340-343 doi: https://doi.org/10.1136/adc.84.4.340

71. Dahlgren J, Wikland KA. Final height in short children born small for gestational age treated with growth hormone. Pediatr Res. 2005;57(2):216-222. doi: https://doi.org/10.1203/01.PDR.0000148716.71231.81

72. Rosilio M, Carel J-C, Ecosse E, Chaussainon J-L. Adult height of prepubertal short children born small for gestational age treated with GH. Eur J Endocrinol. 2005;152(6):835-843. doi: https://doi.org/10.1530/eje.1.01916

73. Thomas M, Beckers D, Brachet C, et al. Adult Height after Growth Hormone Treatment at Pubertal Onset in Short Adolescents Born Small for Gestational Age: Results from a Belgian Registry-Based Study. Int J Endocrinol. 2018;2018(6):1-8. doi: https://doi.org/10.1155/2018/6421243

74. Ranke MB, Lindberg A. Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pfizer International Growth Database). BMC Med Inform Decis Mak. 2011;11(1):38. doi: https://doi.org/10.1186/1472-6947-11-38

75. Fjellestad-Paulsen A, Czernichow P, Brauner R, et al. Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation. Acta Paediatr. 1998;87(5):511-517. doi: https://doi.org/10.1080/08035259850158209

76. Tanaka T, Yokoya S, Seino Y, et al. Long-term efficacy and safety of two doses of growth hormone in short Japanese children born small for gestational age. Horm Res Paediatr. 2011;76(6):411-418. doi: https://doi.org/10.1159/000334152

77. Agut T, León M, Rebollo M, et al. Early identification of brain injury in infants with hypoxic ischemic encephalopathy at high risk for severe impairments: accuracy of MRI performed in the first days of life. BMC Pediatr. 2014;14(1):177. doi: https://doi.org/10.1186/1471-2431-14-177

78. van der Steen M, Pfundt R, Maas SJWH, et al. ACAN gene mutations in short children born sga and response to growth hormone treatment. J Clin Endocrinol Metab. 2017;102(5):1458-1467. doi: https://doi.org/10.1210/jc.2016-2941

79. de Zegher F, Ong K, van Helvoirt M, et al. High-dose growth hormone (gh) treatment in non-gh-deficient children born small for gestational age induces growth responses related to pretreatment gh secretion and associated with a reversible decrease in insulin sensitivity. J Clin Endocrinol Metab. 2002;87(1):148-148. doi: https://doi.org/10.1210/jcem.87.1.8293

80. Leger J, Noel M, Limal JM, Czernichow P. Growth factors and intrauterine growth retardation. II. serum growth hormone, Insulin-Like Growth Factor (IGF) I, and IGF-binding protein 3 levels in children with intrauterine growth retar age 1. Pediatr Res. 1996;40(1):101-107. doi: https://doi.org/10.1203/00006450-199607000-00018

81. Moon J-E, Ko CW. Delayed bone age might accelerate the response to human growth hormone treatment in small for gestational age children with short stature. Int J Endocrinol. 2019;2019(1):1-6. doi: https://doi.org/10.1155/2019/8454303

82. Cutfield WS, Jackson WE, Jefferies C, et al. Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age. J Pediatr. 2003;142(2):113-116. doi: https://doi.org/10.1067/mpd.2003.8

83. Sas T, Mulder P, Aanstoot HJ, et al. Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age. Clin Endocrinol (Oxf). 2001;54(2):243-251. doi: https://doi.org/10.1046/j.1365-2265.2001.01178.x

84. Ahlgren M, Melbye M, Wohlfahrt J, Sørensen TIA. Growth patterns and the risk of breast cancer in women. Int J Gynecol Cancer. 2006;16(s2):569-575. doi: https://doi.org/10.1111/j.1525-1438.2006.00698.x


Review

For citations:


Nagaeva E.V. Short stature due to intrauterine growth retardation. Clinical and hormonal-metabolic features, possibilities of growth-stimulating therapy. Problems of Endocrinology. 2022;68(5):4-13. (In Russ.) https://doi.org/10.14341/probl13178

Views: 2518


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)